Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcturus Therapeutics Holdings (ARCT) Treasury Shares (2018 - 2025)

Arcturus Therapeutics Holdings (ARCT) has disclosed Treasury Shares for 5 consecutive years, with $18786.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Treasury Shares changed 0.0% year-over-year to $18786.0, compared with a TTM value of $18786.0 through Dec 2025, changed 0.0%, and an annual FY2025 reading of $18786.0, changed 0.0% over the prior year.
  • Treasury Shares was $18786.0 for Q4 2025 at Arcturus Therapeutics Holdings, roughly flat from $18786.0 in the prior quarter.
  • Across five years, Treasury Shares topped out at $18786.0 in Q4 2023 and bottomed at $18786.0 in Q4 2023.
  • Average Treasury Shares over 3 years is $18786.0, with a median of $18786.0 recorded in 2023.
  • Peak annual rise in Treasury Shares hit 0.0% in 2024, while the deepest fall reached 0.0% in 2024.
  • Year by year, Treasury Shares stood at $18786.0 in 2023, then changed by 0.0% to $18786.0 in 2024, then changed by 0.0% to $18786.0 in 2025.
  • Business Quant data shows Treasury Shares for ARCT at $18786.0 in Q4 2025, $18786.0 in Q4 2024, and $18786.0 in Q4 2023.